Latest ArticlesTo investigate the pharmacodynamics parameters of Fuscoporia punctata in the ventricular arrhythmia rats to provide a reliable experimental basis for prevention and treatment of arrhythmia.
Thirty-two healthy rats were divided into four groups, which were Fuscoporia punctata low-dose group (0.27 g/kg), medium-dose group (0.81 g/kg), high-dose group (1.35 g/kg) and control group. The rats of 3 Fuscoporia punctata groups were intragastrically administrated for 7 consecutive days (the control group was given the same volume of normal saline). Aconitine was injected via the jugular vein on the seventh day to establish a ventricular arrhythmia model and the electrocardiogram was monitored.
Compared with control group, the occurrence time of arrhythmia in each Fuscoporia punctata group was delayed, and low-dose group and medium-dose group were significantly different from control group (P<0.05, P<0.01). The effect of medium-dose group was the most significant. Compared with control group, the proportions of arrhythmia in low-dose group and medium-dose group were decreased (P>0.05). The rats in medium-dose and high-dose group had sinus rhythm recovery, and medium-dose group (37.5%) was higher than high-dose group (25.0%). The number of dead rats in each Fuscoporia punctata group was less than that of control group, and the time of death was delayed in the medium-dose group.
The Fuscoporia punctata has the protective effect on the ventricular arrhythmia in aconitine-induced rats, which can delay the occurrence and death time of ventricular arrhythmia, and restore the sinus rhythm.
To investigate the effect of Ginko leaf extract and armillariella mellea powders oral solution combined with cerebral circulation therapeutic apparatus in the treatment of post cerebral infarction cognitive dysfunction.
A total of 140 patients with post cerebral infarction cognitive dysfunction were randomly divided into observation group (n=70) and control group (n=70). All patients were treated with donepezil (5 mg/time, once a day), and given cerebral circulation therapeutic apparatus (30 minutes for each treatment, once a day). The observation group was additionally given Ginko leaf extract and armillariella mellea powders oral solution (10 ml/time, three times a day) for 3 months. The Montreal cognitive function assessment (MoCA) scale, Wechsler memory scale (WMS) and activity of daily living (ADL) scale were used to compare the cognitive function changes before and after treatment.
Compared with before treatment, the scores of the MoCA, WMS and ADL scale in two groups after treatment were increased (P<0.05). Compared with control group, the scores of the MoCA, WMS and ADL scale in observation group were higher (P<0.05).
Ginko leaf extract and armillariella mellea powders oral solution combined with cerebral circulation therapeutic apparatus can improve cognitive function and activity of daily living in the patients with cerebral infarction, and promote patients' recovery.
Recently, due to the abuse of hormone, the unresaonable application of broad-spectrum antibiotics, the tumor chemotherapy and the immunosuppressive application after organ transplantation, the probability of fungal infection is increasing, which deeply threats human's health. Chinese herbal monomer or Chinese herbal compound has a good antifungal effect. This review describes the antifungal effects of Chinese herbal monomer and compound, which provides the reference for the treatment of fungal infections by traditional Chinese medicine.
Soy isoflavones (SIF) is a kind of natural estrogen, a secondary metabolite produced during the process of soybean growth. It mainly exists in two nature forms, such as a free glycosidic ligand and the combined one. SIF has a variety of applications, including cardiovascular protective effects, anti-tumor, preventing osteoporosis, neuroprotective and antinervedegeneration, anti-diabetic effects, hepatoprotective effects, immunoregulation effects and esotrogen-like effects. Based on the extensive study, this review summarizes its pharmacological effects and clinical application of SIF and its prospects.
The basic mechanism of osteoporosis is imbalances of bone resorption and bone formation. The incidence of osteoporosis is higher among postmenopausal women, and it is easy to form fracture, especially vertebral fracture. Osteoporosis will influence the patient's quality of life, resulting in disability when condition gets worst. The present method of treatment is to give anti-osteoporosis drugs on the basis of improving lifestyles, keeping physically activities, and correcting bad habits. The goal of treatment is to prevent the fragility fracture. The security of drug therapy is higher, but it has a certain adverse drug reactions. When clinicians choose drugs, it has to be comprehensively evaluated patients' self-conditions, and choose drugs individually for every patient. This article gives summarize of therapeutic method of postmenopausal osteoporosis.
In our country, to define the legality of off-label drug use, to formulate national formulary, to strengthen internal monitoring of the hospital still needs a great effort to be made. Through literature consultation this article describes the related laws and regulations and administration status of off-label drug use at home and abroad, makes a general comparison of off-label use in China and the European Union, the United States and Japan, and to provide the references for regulating off-label drug use in China.
American association of clinical endocrinologists (AACE) and American college of endocrinology (ACE) released 2018 consensus statement of comprehensive type 2 diabetes management algorithm. The new edition contents updated section on new anti-diabetic drugs, such as glucagon like peptide-1 (GLP-1) receptor agonists, dipeptidyl peptidase-4 (DPP-4) inhibitors, sodium-dependent glucose transporter-2 (SGLT-2) inhibitors and degludec, including their clinical trials results. This review describes the interpretation on main points and updates.
As the incidence of bronchial asthma in children is increasing year by year, now it becomes a main chronic diseases endangering children's health, but the level of its diagnosis and control is still not high. Therefore, it is particularly important to standardize the management of asthma prevention and control guidelines. This article introduces the definition, diagnosis and treatment of bronchial asthma in children, and the latest progress of its prevention and control, and provides a certain help for the clinicans to better prevent and control bronchial asthma in children.
With the improvement of perinatal medicine and neonatal resuscitation technique, the survival rate of premature infants is increased greatly. However, as one of the most important complication of premature infants, the incidence of bronchopulmonary dysplasia (BPD) is still going up year by year. In general, the mechanical ventilation is an important factor of BPD. However, the previous clinical trials have no consensus on whether non-invasive ventilation strategies can reduce the incidence of BPD and which strategy can be chosen. This review describes the mechanism of BPD caused by mechanical ventilation, if the non-invasive ventilation can reduce the occurrence of BPD and the best non-invasive ventilation strategy.
In the past few decades, the prevalence of bronchial asthma in children has increased abruptly worldwide. Environmental tobacco smoke (ETS) exposure is a risk factor for respiratory diseases in children, especially bronchial asthma. ETS exposure during prenatal and postnatal life can impair lung development, alter the immune system, and increase the prevalence of bronchial asthma in children. This review describes the effects and mechanisms of ETS on bronchial asthma, and the effects of ETS exposure on the lung health in children and fetal period, and the biomarkers of ETS exposure.